An Act prohibiting discrimination against 340b drug discount program participants
House: Reporting date extended to Friday, July 31, 2026
Summary
The bill adds new sections to state law that forbid drug insurers, manufacturers, and distributors from treating 340B‑covered entities or their contract pharmacies differently in reimbursement, fees, network participation, or claim handling. It also protects patients’ right to get 340B drugs from the provider they choose. The aim is to keep the federal 340B discount program working fairly in the Commonwealth.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when H 4490 changes status, plus AI-powered summaries and stage predictions.
Sign up free